# High-Dose Insulin Therapy for Refractory Shock in a Polypharmacy Overdose of Calcium Channel Blocker and Oral Hypoglycemic Agent: A Case Report and Literature Review

**Authors:** Vinayak S R, Bipenthung N Jami, Austin J Mangaly, Krishnakumar R S, Gladson Vineeth, Chandni Radhakrishnan

PMC · DOI: 10.7759/cureus.77853 · 2025-01-22

## TL;DR

This case report describes the successful use of high-dose insulin therapy in treating a severe overdose involving a calcium channel blocker and an oral hypoglycemic agent.

## Contribution

The novelty lies in demonstrating HDI therapy's effectiveness in a complex polypharmacy overdose case when conventional treatments failed.

## Key findings

- High-dose insulin therapy improved the patient's condition after conventional treatments failed.
- The case highlights HDI as a promising treatment for refractory shock in polypharmacy overdose scenarios.
- Literature review supports HDI as a potential therapeutic option in similar overdose cases.

## Abstract

We report a case of polypharmacy overdose involving a calcium (Ca) channel blocker and an oral hypoglycemic agent, where conventional therapies failed to obtain the desired clinical outcome. High-dose insulin (HDI) therapy, a promising treatment regime in this regard, was carried out for our patient, and her condition improved over the subsequent days.

## Full-text entities

- **Diseases:** Shock (MESH:D012769)
- **Chemicals:** Oral Hypoglycemic Agent (-), Insulin (MESH:D007328)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC11845794